STOCK TITAN
  1. Home
  2. Sec-filings
  3. ESAB
  4. [Form 4] ESAB Corp Insider Trading Activity

ESAB Corp (NYSE: ESAB) president adds stock from vesting and grants

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

ESAB Corp President, Fab Tech Olivier Biebuyck reported compensation-related share activity. He exercised 1,408 restricted stock units into an equal number of common shares and received a separate grant or award of 5,320 common shares. ESAB withheld 662 shares and 2,535 shares at $107.0200 per share to cover tax liabilities on these vestings, with no shares sold on the market. Following these transactions, Biebuyck directly holds 19,378 shares of ESAB common stock.

Positive

  • None.

Negative

  • None.

Insights

Routine equity vesting and tax withholding with no open‑market trades.

Olivier Biebuyck, President, Fab Tech at ESAB Corp, reported routine equity compensation events. 1,408 restricted stock units converted into common stock, and 5,320 additional shares were granted as stock awards tied to service and performance conditions.

Footnotes explain that 662 shares and 2,535 shares were withheld by ESAB at $107.0200 per share to satisfy tax liabilities on these vestings, rather than being sold in the market. After these non‑market transactions, Biebuyck holds 19,378 common shares directly, indicating a higher equity stake and no discretionary buying or selling.

Insider Biebuyck Olivier
Role President, Fab Tech
Type Security Shares Price Value
Exercise Restricted Stock Units 1,408 $0.00 --
Exercise Common stock, par value $0.001 1,408 $0.00 --
Tax Withholding Common stock, par value $0.001 662 $107.02 $71K
Grant/Award Common stock, par value $0.001 5,320 $0.00 --
Tax Withholding Common stock, par value $0.001 2,535 $107.02 $271K
Holdings After Transaction: Restricted Stock Units — 0 shares (Direct); Common stock, par value $0.001 — 17,255 shares (Direct)
Footnotes (1)
  1. Each restricted stock unit represents a contingent right to receive one share of common stock of ESAB Corporation. Represents shares withheld by ESAB Corporation in connection with net share settlement to satisfy the reporting person's tax liability based upon the vesting of restricted stock units. No shares were sold by the reporting person to satisfy this tax liability. Represents shares vested pursuant to performance-based restricted stock units granted on March 8, 2023, which vesting was subject to the certification of certain performance criteria. The award vested on March 8, 2026. Represents shares withheld by ESAB Corporation in connection with net share settlement to satisfy the reporting person's tax liability based upon the vesting of performance-based restricted stock units. No shares were sold by the reporting person to satisfy this tax liability. This award represents restricted stock units that vest in three equal annual installments beginning on the first anniversary of the grant date. All remaining restricted stock units from this award vested on March 8, 2026.
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Biebuyck Olivier
(Last) (First) (Middle)
909 ROSE AVE, 8TH FLOOR
(Street)
NORTH BETHESDA MD 20852
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
ESAB Corp [ ESAB ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
President, Fab Tech
3. Date of Earliest Transaction (Month/Day/Year)
03/09/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common stock, par value $0.001 03/09/2026 M 1,408 A (1) 17,255 D
Common stock, par value $0.001 03/09/2026 F 662(2) D $107.02 16,593 D
Common stock, par value $0.001 03/09/2026 A 5,320 A (3) 21,913 D
Common stock, par value $0.001 03/09/2026 F 2,535(4) D $107.02 19,378 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units (1) 03/09/2026 M 1,408 03/08/2024(5) 03/08/2026 Common stock, par value $0.001 1,408 $0 0 D
Explanation of Responses:
1. Each restricted stock unit represents a contingent right to receive one share of common stock of ESAB Corporation.
2. Represents shares withheld by ESAB Corporation in connection with net share settlement to satisfy the reporting person's tax liability based upon the vesting of restricted stock units. No shares were sold by the reporting person to satisfy this tax liability.
3. Represents shares vested pursuant to performance-based restricted stock units granted on March 8, 2023, which vesting was subject to the certification of certain performance criteria. The award vested on March 8, 2026.
4. Represents shares withheld by ESAB Corporation in connection with net share settlement to satisfy the reporting person's tax liability based upon the vesting of performance-based restricted stock units. No shares were sold by the reporting person to satisfy this tax liability.
5. This award represents restricted stock units that vest in three equal annual installments beginning on the first anniversary of the grant date. All remaining restricted stock units from this award vested on March 8, 2026.
Remarks:
/s/ Curtis E. Jewell, Attorney-in-Fact 03/11/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What did ESAB (ESAB) executive Olivier Biebuyck report in this Form 4?

Olivier Biebuyck reported equity compensation activity, including vesting of 1,408 restricted stock units and a separate grant of 5,320 common shares. Shares were also withheld to cover tax obligations related to these awards, with no open-market share sales disclosed.

Did Olivier Biebuyck buy or sell ESAB (ESAB) shares on the open market?

The filing shows no open-market purchases or sales. Shares labeled with code F were withheld by ESAB to pay tax liabilities on vested awards, at a price of $107.0200 per share, rather than sold by Biebuyck into the market.

How many ESAB (ESAB) shares did Olivier Biebuyck acquire through awards and vesting?

He acquired 1,408 common shares upon conversion of restricted stock units and received an additional 5,320 common shares as a grant or award. These shares arose from equity compensation rather than market purchases, increasing his direct ownership stake in ESAB.

Why were some ESAB (ESAB) shares classified as dispositions in this Form 4?

Dispositions coded F reflect shares withheld by ESAB to satisfy Olivier Biebuyck’s tax liabilities from vesting awards. Specifically, 662 shares and 2,535 shares were withheld at $107.0200 per share, with the footnotes clarifying no shares were sold by him to pay these taxes.

What is Olivier Biebuyck’s ESAB (ESAB) share ownership after these transactions?

After the reported equity compensation activity and tax-withholding events, Olivier Biebuyck directly owns 19,378 shares of ESAB common stock. This figure reflects his updated post-transaction holdings, combining vested awards, new grants, and shares withheld for tax obligations.

What do the restricted stock unit and performance-based vesting details mean for ESAB (ESAB)?

The filing notes that each restricted stock unit converts into one ESAB common share and that certain performance-based units granted March 8, 2023 vested March 8, 2026. This shows ESAB using performance-linked equity awards to align executive pay with corporate results over multi-year periods.